Rudolph Bucheim introduced the concept of optimum drug therapy and optimal use of drugs in the treatment of disease in 1849. However, clinical pharmacology as an academic discipline began after intensive researches into the appropriate use of antimalarial drugs during World War II. The word "Clinical Pharmacology" was first used in the title "Clinical Pharmacology Laboratory" led by Albert Sjoerdsma, with the support of James Shannon of the US National Heart Institute, in the early 1950s. There was also a clinical working group within the Department of Pharmacology at Cornell University College of Medicine led by Harry Gold and Walter Modell. In the US, during the 1950s and 1960s, clinical pharmacological research and programs fostering clinical pharmacologists expanded greatly, with the establishment of 10 clinical pharmacology centers within university hospitals supported by NIGMS. Simultaneously, in Western Europe, there was a rapidly growing need for collaboration between the pharmaceutical industry and academia for the clinical development of new drugs, and clinical pharmacology was dawning as a discipline at Hammesmith Hospital and University College Hospital in the UK. The thalidomide tragedy in the late 1950s demonstrated the urgent need to develop clinical pharmacology departments in universities. In the 1960s, the Karolinska Institute of Sweden established a clinical pharmacology department in Huddinge Hospital, which became the epicenter of clinical pharmacology development throughout Western Europe. Among Asian countries, the pharmaceutical industry developed early only in Japan. The Japanese pharmaceutical industry developed new global drugs as early as the 1960s. Scholars who received clinical pharmacology training in Europe and the US during this period facilitated the establishment of clinical pharmacology programs in medical institutes from the late 1960s to the 1970s. However, despite the WHO's endeavor to expand clinical pharmacology to other countries in the early 1970s, this did not extend to the Asian medical world beyond Japan. The notion of clinical pharmacology was first introduced in the Korean medical community in the early 1970s by professor KS Lee from SUNY Downstate Medical Center in New York while he was working as a visiting professor in the Department of Pharmacology at Seoul National University (SNU) College of Medicine. Dr. YW Cho became the Chair of the Pharmacology Department of Chung-Ang University College of Medicine in 1974 after finishing fellowship training in clinical pharmacology in the US. Though he introduced clinical pharmacology to Korea and conducted clinical pharmacology studies, he did not make a large impact in academia. However, since then, more young pharmacologists and clinicians have begun to recognize the importance of clinical pharmacology in the development and optimal use of new and existing drugs.
Burgeoning of Clinical Pharmacology in Korea (1988 Korea ( -1994 With the number of trained clinical pharmacologists increasing after 1995, the academic activities of KSCPT became more focused on core knowledge for clinical pharmacology. KSCPT held symposiums on optimal drug therapy, therapeutic drug monitoring, new drug post-marketing surveillance (PMS), clinical evaluation of new drugs, clinical trial methodology, and DUR. Along with the progress of ICH, clinical studies of new drugs and approval systems became more scientific and globalized. In response, KSCPT organized workshops and symposia related to guidelines, such as ICH E5 and E6, in an effort to lead the change in Korea's medical and pharmaceutical environment. As such, even when global clinical trials were not legally allowed in Korea, KSCPT played a role as one of the most essential medical societies to improve the national capacity to prepare for the future, including globalization of the medical environment and drug development of local pharmaceutical companies.
As 
Establishment of Clinical Pharmacology Organizations in Korea
In the 1990s, clinical pharmacology organizations often started with 1-2 professors at SNU Hospital, Inha University Hospital, Yonsei University Severance Hospital, Inje University Busan Paik Hospital, or Soonchunhyang University College of Medicine. Their informal training programs generated a few young clinical pharmacologists. Clinical pharmacology education for undergraduate students was established only at a few universities.
However, entering the 2000s, two governmental policies enacting separation of IND and NDA and separation of prescription and dispensing, clearly identified the need for clinical pharmacologists within the medical society in Korea. In 2004, the government began to support the establishment of clinical trial infrastructures within university hospitals to promote clinical trials (RCTC programs). Accordingly, large university hospitals in the Seoul metropolitan area and major local cities began to realize that it was essential to secure clinical pharmacologists and establish clinical pharmacology departments within their hospitals to host the RCTC. Thus, there has been active recruitment of young clinical pharmacologists and the establishment of clinical pharmacology organizations after 2004. As shown in Table 1 and Figure 3 , 15 independent clinical pharmacology departments were established at university hospitals, and 7 clinical pharmacology organizations were opened as divisions of internal medicine or as departments of CTCs. Currently, there are 64 clinical pharmacology professors, including those with dual appointments. There are also several clinical pharmacologists who are working as faculty members in pharmacology departments or clinical trial centers without officially established clinical pharmacology organizations.
In 2005, the University of Ulsan (Asan Medical Center) and Inje University established independent departments at medical schools ('Gyosil' in Korean), following such a development at Soonchunhyang University in 1996. In Inje University, the clinical pharmacology department at the medical school has been established in line with the clinical pharmacology department at its affiliated hospital. Since its development in 1996, the department has performed research, consulting, and educational activities in clinical pharmacology.
In later years, Kyung Hee University, SNU, and Inha University established clinical pharmacology departments within their medical schools. More recently, independent clinical pharmacology departments were established in both CHA Medical School and Bundang CHA Medical Center. Currently, 7 medical schools have such independent departments. In Yonsei University, clinical pharmacology remains a division of the Pharmacology Department of the medical school (Table  1) . With the growing number of RCTC establishments in major hospitals nationwide, independent clinical pharmacology departments have been established in hospitals, and the demand for clinical pharmacologists far exceeded the supply until recently. Young doctors trained in the 1990s served as professors of clinical pharmacology for several universities in the early 2000s. Some of them began their professorial activities based on RCTCs.
Changes of Educational and Training Activities in Korea
In the 1990s, clinical pharmacology organizations were established in SNU, Clinical pharmacology was introduced to Korea in the 1990s, much later than in Western countries. However, its growth has been so intense, especially since the 2000s, that Korean activities have since caught up or surpassed activities in other countries. Despite this success, there are still an insufficient number of clinical pharmacologists in academia and hospitals. Moreover, clinical pharmacologists are desperately needed to work at MFDS or in the pharmaceutical industry as well as in academia. To this end, clinical pharmacology must be acknowledged as an essential discipline throughout Korean society.
